oxybutynin has been researched along with Oral Submucous Fibrosis in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Oral Submucous Fibrosis: Irreversible FIBROSIS of the submucosal tissue of the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nihadha, PM | 1 |
| Chugh, A | 1 |
| Kaur, A | 1 |
| Kumar, S | 1 |
| Naveen, KH | 1 |
| Bhatia, PK | 1 |
| Kumar, P | 1 |
| Chaudhry, K | 1 |
1 trial available for oxybutynin and Oral Submucous Fibrosis
| Article | Year |
|---|---|
Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: a triple blinded, randomised control trial.
Topics: Analgesia; Analgesics, Opioid; Fentanyl; Humans; Oral Submucous Fibrosis; Pain; Transdermal Patch | 2022 |